Vis enkel innførsel

dc.contributor.authorWaldock, Joanna
dc.contributor.authorZheng, Lingyi
dc.contributor.authorRemarque, Edmond J.
dc.contributor.authorCivet, Alexandre
dc.contributor.authorHu, Branda
dc.contributor.authorJalloh, Sarah Larteley Lartey
dc.contributor.authorCox, Rebecca Jane
dc.contributor.authorHo, Sammy
dc.contributor.authorHöschler, Katja
dc.contributor.authorOllinger, Thierry
dc.contributor.authorTrombetta, Claudia Maria
dc.contributor.authorEngelhardt, Othmar
dc.contributor.authorCaillet, Catherine
dc.date.accessioned2022-04-20T09:46:18Z
dc.date.available2022-04-20T09:46:18Z
dc.date.created2021-09-29T12:06:14Z
dc.date.issued2021
dc.identifier.issn2379-5042
dc.identifier.urihttps://hdl.handle.net/11250/2991563
dc.description.abstractThe hemagglutination inhibition (HAI) assay is an established technique for assessing influenza immunity, through measurement of antihemagglutinin antibodies. Improved reproducibility of this assay is required to provide meaningful data across different testing laboratories. This study assessed the impact of harmonizing the HAI assay protocol/reagents and using standards on interlaboratory variability. Human pre- and postvaccination sera from individuals (n = 30) vaccinated against influenza were tested across six laboratories. We used a design of experiment (DOE) method to evaluate the impact of assay parameters on interlaboratory HAI assay variability. Statistical and mathematical approaches were used for data analysis. We developed a consensus protocol and assessed its performance against in-house HAI testing. We additionally tested the performance of several potential biological standards. In-house testing with four reassortant viruses showed considerable interlaboratory variation (geometric coefficient of variation [GCV] range of 50% to 117%). The age, concentration of turkey red blood cells, incubation duration, and temperature were key assay parameters affecting variability. Use of a consensus protocol with common reagents, including viruses, significantly reduced GCV between laboratories to 22% to 54%. Pooled postvaccination human sera from different vaccination campaigns were effective as biological standards. Our results demonstrate that the harmonization of protocols and critical reagents is effective in reducing interlaboratory variability in HAI assay results and that pools of postvaccination human sera have potential as biological standards that can be used over multiple vaccination campaigns. Moreover, the use of standards together with in-house protocols is as potent as the use of common protocols and reagents in reducing interlaboratory variability.en_US
dc.language.isoengen_US
dc.publisherASMen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleAssay harmonization and use of biological standards to improve the reproducibility of the hemagglutination inhibition assay: A FLUCOP collaborative studyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 The Author(s)en_US
dc.source.articlenumbere00567-21en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1128/mSphere.00567-21
dc.identifier.cristin1940504
dc.source.journalmSphereen_US
dc.relation.projectNorges forskningsråd: 271160en_US
dc.relation.projectNorges forskningsråd: 284930en_US
dc.identifier.citationmSphere. 2021, 6 (4), e00567-21.en_US
dc.source.volume6en_US
dc.source.issue4en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal